线粒体DNA拷贝数和阿尔茨海默病和帕金森病的发生
Pei Qin1, Xiaojuan Chen2, Panpan Ma2
1Center for Clinical Epidemiology and Evidence-Based Medicine, Shenzhen Qianhai Shekou Free Trade Zone Hospital, Shenzhen, Guangdong, China.
Mitochondrion
|March 29, 2025
概括
线粒体DNA复制号 (mtDNA-CN) 与阿尔茨海默病 (AD) 或帕金森病 (PD) 没有因果关系. 然而,AD可能会降低mtDNA-CN,表明其作为AD生物标志物的潜力.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 生物标志物研究 生物标志物研究
背景情况:
- 对于线粒体DNA复制数 (mtDNA-CN) 与神经退行性疾病,如阿尔茨海默氏症 (AD) 和帕金森病 (PD) 之间的关系缺乏明确的理解.
- 现有的mtDNA-CN和AD/PD观测研究存在局限性,它们的因果关系尚不清楚.
研究的目的:
- 系统地审查关于mtDNA-CN和AD/PD之间的关联的观察性研究.
- 进行双向的双样本孟德尔随机化 (MR) 研究,研究mtDNA-CN,AD和PD之间的因果关系.
主要方法:
- 在PubMed,Embase和Web of Science的系统文献搜索2025年1月之前发表的研究.
- 在双向MR研究中使用逆变异加权 (IVW) 方法进行主要因果关系分析.
- 进行敏感性和复制性分析,以确保研究结果的可靠性.
主要成果:
- 系统性审查确定了关于mtDNA-CN和AD/PD的有限的观察性研究,主要是病例控制.
- 双向MR分析发现mtDNA-CN对AD或PD没有因果关系.
- 基因预测的AD与mtDNA-CN下降有关,但不是反之.
结论:
- 目前的证据不支持mtDNA-CN在AD和PD发展中的因果作用.
- 阿尔茨海默病可能导致mtDNA-CN水平的降低.
- mtDNA-CN显示出作为阿尔茨海默氏症生物标志物的潜力.
相关概念视频
Animal Mitochondrial Genetics
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...


